Loading company…
Riskpilot
← Back to search
Sign in
Get full access
IRIS AS
AS
Active
Org 974387913
Valkendorfsgaten 5, 5012 Bergen
Medical specialists activities · NACE 8622
Est. 1995
6 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 11,3M
+1% vs 2023
EBITDA margin
20.0%
-6% vs 2023
Equity ratio
63.0%
Financial strength
Net profit 2024
NOK 1,6M
-9% vs 2023
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
2M
2020
3M
+50%
2021
2M
-33%
2022
2M
0%
2023
2M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 11,3M
+1%
EBITDA
NOK 2,3M
-6%
Net profit
NOK 1,6M
-9%
Total assets
NOK 8M
-1%
Equity
NOK 5,1M
+9%
Employees
6
—
Company information
Legal name
IRIS AS
Org number
974387913
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. januar 1995
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Valkendorfsgaten 5, 5012 Bergen
Email
gpaccsupport@iris.co.uk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
3M
7M
10M
14M
10M
2020
12M
2021
10M
2022
11M
2023
11M
2024
EBITDA
NOK millions
0M
1M
2M
3M
3M
2M
2020
3M
2021
2M
2022
2M
2023
2M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
10 480
11 880
10 271
11 133
11 295
Staff expenses
−2 334
−2 359
−2 224
−2 379
−2 369
EBITDA
2 477
3 060
2 000
2 406
2 259
Depreciation & amort.
−116
−105
−236
−309
−307
EBIT
2 361
2 955
1 764
2 097
1 952
Net financials
−164
100
648
141
97
Profit before tax
2 197
3 055
2 412
2 237
2 049
Tax
413
643
388
474
453
Net profit
1 785
2 412
2 024
1 763
1 596
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 577
6 726
7 100
8 140
8 022
Equity
2 956
3 868
4 392
4 655
5 051
Long-term debt
16
8
21
6
0
Short-term debt
2 605
2 850
2 687
3 479
2 970
Total debt
2 621
2 859
2 708
3 485
2 970
Financial ratios
5-year trend
EBITDA margin
20.0%
This company
15.8%
Market median
+27% vs market
2020
2024
Equity ratio
63.0%
This company
38.2%
Market median
+65% vs market
2020
2024
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
2020
2024
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
2020
2024
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
2020
2024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SO
Signe Ose
Deputy Member
Deputy Member
1995
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JA
Jan Askvik
Chairman
1995
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
IRIS AS
(this company)
Bergen Øyelegesenter As
OPTERA AS
Board network connections
Board members of IRIS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Signe Ose
Deputy Member
0 companies
Jan Askvik
Chairman
0 companies